BBIO icon

BridgeBio Pharma
BBIO

Overview Fund Trends Analyst Outlook Journalist POV

61 hedge funds and large institutions have $2.7B invested in BridgeBio Pharma in 2019 Q2 according to their latest regulatory filings, with 61 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

Holders
61
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
6
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$995M
2
+$718M
3
+$182M
4
PA
Perceptive Advisors
New York
+$181M
5
ACM
Aisling Capital Management
New York
+$103M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$2.35M
27
$2.02M
28
$1.76M
29
$1.62M
30
$1.44M
31
$1.35M
32
$1.35M
33
$1.04M
34
$1.02M
35
$936K
36
$809K
37
$801K
38
$701K
39
$677K
40
$675K
41
$674K
42
$601K
43
$587K
44
$539K
45
$476K
46
$467K
47
$458K
48
$356K
49
$270K
50
$255K
1
2
3